Remove Peripheral Arterial Disease Remove Physiology Remove Quality of Life
article thumbnail

CorVascular’s VasoGuard Earns FDA 510(k) Clearance

DAIC

mtaschetta-millane Mon, 07/29/2024 - 09:16 July 29, 2024 — CorVascular , a leading producer of peripheral arterial disease (PAD) / peripheral vascular disease (PVD) testing devices, today announced the U.S. Food and Drug Administration (FDA) has cleared its VasoGuard V-Series as Class II medical devices.

article thumbnail

Physiology Friday #196: Resistance Training and Heart Health

Physiologically Speaking

Welcome to the Physiology Friday newsletter. Physiologically Speaking is a reader-supported publication. Finally — and a benefit that applies to all exercise in general and not just resistance exercise — there appears to be a benefit of training on depression and anxiety, quality of life, and sleep quality.

article thumbnail

Physiology Friday #196: Resistance Training and Heart Health

Physiologically Speaking

Welcome to the Physiology Friday newsletter. Physiologically Speaking is a reader-supported publication. Finally — and a benefit that applies to all exercise in general and not just resistance exercise — there appears to be a benefit of training on depression and anxiety, quality of life, and sleep quality.